packageDinutuximab

dinutuximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dinutuximab is a monoclonal antibody anticancer drug used to treat neuroblastoma. It is authorised in the European Union, though one EU product has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q21011236 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dinutuximab
ATC codes:L01FX06
DrugBank:DB09077
Wikidata:Q21011236

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown